HILDA RAISCH: Open Payments
NPI 1376805713 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$173 in 9 payments from 7 companies in 2025. Trend: 2023 $1,792 · 2024 $1,855 · 2025 $173
Food & beverage: $173
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $48 |
| ABBVIE INC. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Amgen Inc. | 1 | $16 |
Products named: VRAYLAR, Rybelsus, JARDIANCE, CAPLYTA, MOUNJARO, XIFAXAN, KRYSTEXXA.
Industry payments across MD — which companies pay providers there.
